Internal and external factors disturb capital sentiment, and the three major stock indexes of a share reappear and adjust

On Monday, the A share market showed an adjustment trend. Real estate, Baijiu and new energy sectors were weakening, dragging down the three major stock indexes, and the gem was the lowest point in the new year. As of the close, the Shanghai Composite Index closed at 316713 points, down 2.61%; Shenzhen composite index reported 1152021 points, down 3.67%; Gem index reported 246204 points, down 4.20%.

Yesterday, the new energy sector retreated sharply, leading to the decline of the gem index with high weight of new energy. As of the closing, Shenwan power equipment index fell by 5.43%, the leading lithium battery with trillion market value Contemporary Amperex Technology Co.Limited(300750) fell by 7.27%, and Eve Energy Co.Ltd(300014) , Yunnan Energy New Material Co.Ltd(002812) , Sungrow Power Supply Co.Ltd(300274) , etc. fell by more than 5%.

Yin bin, chief analyst of new energy at Huaxin securities, said that the recent outbreaks in Shanghai, Jiangsu, Jilin and other places had a great impact on the automobile industry. The production scheduling and shipment of enterprises in some epidemic areas were affected by stages, exacerbating the negative expectation of the market for the new energy automobile industry.

“We believe that the epidemic may curb short-term demand and further increase the sector shock. However, on the whole, based on the ‘rush loading’ market with China’s subsidies cleared at the end of the year and maintaining the global sales forecast of 9.5 million to 10 million in 2022, the demand of the new energy vehicle industry chain will continue to increase, and the performance cashability of the head enterprises is still strong. It is suggested to bargain hunting and layout high-quality assets.” Yin Bin thinks.

Although the weight sector is depressed as a whole, there are still local hot spots on the disk. Yesterday, in the opening call auction stage, the logistics sector showed a strong momentum. The gem varieties Jiangsu Xinning Modern Logistics Co.Ltd(300013) , Jiangsu Feiliks International Logistics Inc(300240) and Jiangsu Feiliks International Logistics Inc(300240) all opened with a limit of 20%, and most other logistics stocks also opened higher. As of the close, Shenwan logistics index rose 2.29% against the trend Jiangsu Xinning Modern Logistics Co.Ltd(300013) harvest 20% range “one word limit”, Jiangsu Feiliks International Logistics Inc(300240) , Pegasus international, Beijing Changjiu Logistics Corp(603569) and other multi stock limit, industry leader S.F.Holding Co.Ltd(002352) rose 2.57%.

Citic Securities Company Limited(600030) transportation analyst Hu Shimin believes that the resumption of the impact on the express industry after the outbreak of the epidemic in 2020 is expected to usher in a compensatory demand rebound of 1-2 months after the inflection point of the epidemic. We still maintain the expectation of 15% to 20% growth rate of parts in the industry in 2022, and pay attention to the layout opportunities of express leaders brought by short-term disturbance.

The Chinese medicine sector also performed strongly. As one of the leading gainers in the current round of traditional Chinese medicine stocks, Dali Pharmaceutical Co.Ltd(603963) previously, the share price gained multiple limits. In early trading yesterday, affected by the profit taking of funds and the market, the share price hit the limit less than 3 minutes after Dali Pharmaceutical Co.Ltd(603963) opening. Subsequently, short-term hot money poured in again, pushing the company’s share price up again. At about 9:50 in the morning trading, the Dali Pharmaceutical Co.Ltd(603963) share price hit the daily limit and completed the “ground Sky board” within 20 minutes, and the daily limit situation remained until the closing.

In addition to Dali Pharmaceutical Co.Ltd(603963) , other popular traditional Chinese medicine stocks followed up one after another, and the share prices of Jiangsu Kanion Pharmaceutical Co.Ltd(600557) , Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) and others hit new highs in the year.

Caixin Securities believes that with the gradual implementation of the 14th five year plan for the development of traditional Chinese medicine, the high-quality development of traditional Chinese medicine will be greatly promoted. With the important role of traditional Chinese medicine in covid-19 epidemic prevention and the deepening aging of China, the demand for traditional Chinese medicine may be gradually released, and the prosperity of the industry is expected to be boosted.

In terms of funds, recently, some market funds were worried that the tightening of monetary policy of the Federal Reserve and the rise of US bond interest rate would have an impact on the A-share market. Yesterday, the northward funds flowed out unilaterally all day, with a net sales of 5.762 billion yuan as of the closing.

China International Capital Corporation Limited(601995) chief strategist Wang Hanfeng believes that “structurally, ‘steady growth’ may still be the main line of the market in the bottom grinding period, and the areas where the performance of the first quarter exceeds expectations also deserve attention. In the future, with the gradual easing of overseas supply risks, the tightening of liquidity and the gradual stabilization of China’s growth expectation, the growth style with high prosperity may gradually usher in a turnaround.”

- Advertisment -